Determination of fluoxeline and norfluoxetine in plasma by a modified high performance reversed phase liquid chromatographic method with fluorescence detection

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 18, 2004, Pages 2957-2972

  Atta Politou, Julia ^a   Fraskou, P ^a   Koupparis, M ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Fluoxetine; HPLC; Norfluoxetine; Plasma

Indexed keywords

ALCOHOLS; ALKALINITY; FLUORESCENCE; LIQUID CHROMATOGRAPHY; PH EFFECTS;

ANTIDEPRESSANT THERAPY; BIOAVAILABILITY; RAPID REVERSED PHASE LIQUID CHROMATOGRAPHY;

PLASMA ACCELERATORS;

ACETONITRILE; ANTIDEPRESSANT AGENT; FLUOXETINE; HEXANE; ISOPENTYL ALCOHOL; NORFLUOXETINE; PROTRIPTYLINE;

ACCURACY; AQUEOUS SOLUTION; ARTICLE; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG DETERMINATION; HUMAN; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 5444230837     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-200030902     Document Type: Article

References (23)

1. Benfield, P.; Heel, R.C.; Lewis, S.P. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986, 32, 481-508.
2. Harris, M.G.; Benfield, P. Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in older patients with depressive illness. Drugs Aging 1995, 6 (1), 64-84.
3. Sommi, R.W.; Crimson, L.M.; Bowden, C.L. Fluoxetine: a serotonin-specific, second-generation antidepressant. Pharmacotherapy 1987, 7, 1-15.
4. Fontanille, P.; Jourdil, N.; Villier, C.; Bessard, G. Direct analysis of fluoxetine and norfluoxetine by gas chromatography with nitrogen-phosphorus detection. J. Chrom. B: Biomed. Appl. 1997, 692 (2), 337-343.
5. Dixit, V.; Nguyen, H. Solid phase extraction of fluoxetine and norfluoxetine from serum with gas chromatography-electron-capture detection. J. Chrom. 1991, 563, 379-384.
6. Addison, R.S.; Franklin, M.E.; Hooper, W.D. Sensitive high-throughput gas chromatographic-mass spectrometric assay for fluoxetine and norfluoxetine in human plasma and its application to pharmacokinetic studies. J. Chrom. B: Biomed. Appl. 1998, 716 (1-2), 153-160.
7. Suckow, R.F.; Zhang, M.F.; Cooper, T.B. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clin. Chem. 1992, 38 (9), 1756-1761.
8. Kristoffersen, L.; Bugge, A.; Lundeanes, E.; Slordal, L. Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high performance liquid chromatography with ultraviolet and fluorescence detection. J. Chrom. B: Biomed. Appl. 1999, 734 (2), 229-246.
9. Raggi, M.A.; Mandrioli, R.; Casamenti, G.; Bugamelli, F.; Voltera, V. Determination of fluoxetine and norfluoxetine in human plasma by high pressure liquid chromatography with fluorescence detection. J. Pharm. Biomed. Anal. 1998, 18 (1-2), 193-199.
10. Gupta, R.N.; Steiner, M. Determination of fluoxetine and norfluoxetine in serum by liquid chromatography with fluorescence detection. J. Liq. Chromatogr. 1990, 13 (19), 3785-3797.
11. Wong, S.H.Y.; Dellafera, S.S.; Fernandes, R. Determination of fluoxetine and norfluoxetine by high performance liquid chromatography. J. Chromatogr. 1990, 499, 601-608.
12. Nichols, J.H.; Charlson, J.R.; Lawson, G.M. Automated HPLC assay of fluoxetine and norfluoxetine in serum. Clin. Chem. 1994, 40 (7), 1312-1316.
13. Orsulak, P.J.; Kenney, J.T.; Debus, J.R.; Crowley, G.; Wittman, P.D. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC, with ultraviolet detection. Clin. Chem. 1988, 34 (9), 1875-1878.
14. Llerena, A.; Dorado, P.; Berecz, R. Determination of fluoxetine and norfluoxetine in human plasma by high performance liquid chromatography with ultraviolet detection in psychiatric patients. J. Chrom. B: Anal. Technol. Biomed. Life Sci. 2003, 783 (1), 25-31.
15. Thomare, P.; Wang, K.; Van der Meersch-Mougeot, V.; Diquet, B. Sensitive micromethod for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma. J. Chromatogr. Biomed. Appl. 1992, 583, 217-221.
16. Titier, K.; Castaing, N.; Scotto-Gomez, E.; Pehourcq, F.; Moore, N.; Molimard, M. High performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their metabolites in plasma after overdose. Ther. Drug. Monit. 2003, 25 (5), 581-587.
17. Li, C.; Ji, Z.H.; Nan, F.J.; Shao, Q.X.; Liu, P.; Dai, J.Y. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard. Rapid Commun. Mass Spectrom. 2002, 16 (19), 1844-1850.
18. Sutherland, F.C.W.; Badenhorst, D.; de-Jager, A.D.; Scanes, T.; Hundt, H.K.T. Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma. J. Chrom. A. 2001, 914 (1-2), 45-51.
19. Eerkes, A.; Weng, ND.; King, M.; Du, A.; Shou, W.Z. A sensitive and high-throughput LC-MS-MS method using a silica column and an aqueous-organic mobile phase for the analysis of fluoxetine and norfluoxetine in human plasma. J. Liq. Chrom. Relat. Technol. 2002, 25 (8), 1215-1227.
20. Gatti, G.; Bonomi, I.; Marchiselli, R.; Fattore, C.; Spina, E. Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography. J. Chrom. B: Anal. Technol. Biomed. Life Sci. 2003, 784 (2), 375-383.
21. Pichini, S.; Pacifici, R.; Altieri, I.; Pellegrini, M.; Zuccaro, P. Stereoselective determination of fluoxetine and norfluoxetine enantiomers in plasma samples by high performance liquid chromatography. J. Liq. Chrom. Relat. Technol. 1996, 19 (12), 1927-1935.
22. Ulrich, S. Direct stereoselective assay of fluoxetine and norfluoxetine enantiomers in human plasma or serum by two-dimensional gas-liquid chromatography with nitrogen-phosphorus selective detection. J. Chrom. B: Anal. Technol. Biomed. Life Sci. 2003, 783 (2), 481-490.
23. Desiderio, C.; Rudaz, S.; Raggi, M.A.; Fanali, S. Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis. Electrophoresis 1999, 20 (17), 3432-3438.